Nutritional priorities to support GLP-1 therapy for Obesity: A joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and the Obesity Society
After stopping the drugs, people experience a return of cravings and hunger, and most people in clinical trials gain back 50 percent of weight lost in 12 to 18 months. These Drugs Are Part of a Long-Term Solution Because of the risk of rebound weight gain after stopping semaglutide, people prescribed Wegovy for obesity may need to take the drug for the rest of their lives
The food lists for GLP-1 users and recommended foods on semaglutide can guide a less restrictive approach
Only a prescriber who understands a patients medical history, health conditions, and other medications can determine whether a GLP-1 is the best medication for an older adult with diabetes or obesity
Recalculate using the formula in the section above, or reference the conversion table
doi:10.1038/s41591-022-02026-4 Retrieved from Jiang, R